Significant differences in markers of oxidant injury between idiopathic and bronchopulmonary-dysplasia-associated pulmonary hypertension in children

Pulmonary Medicine

Volumn , Issue , 2012, Pages

  Vera, Kimberly B ^a   Moore, Donald ^a   Flack, English ^a   Liske, Michael ^a   Summar, Marshall ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ISOPROSTANE DERIVATIVE; PROSTACYCLIN; SILDENAFIL;

ADOLESCENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FEMALE; HEART CATHETERIZATION; HOME OXYGEN THERAPY; HUMAN; LUNG DYSPLASIA; MALE; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCHOOL CHILD;

EID: 84876509337     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2012/301475     Document Type: Article

References (13)

1. Yung D., Widlitz A. C., Rosenzweig E. B., Kerstein D., Maislin G., Barst R. J., Outcomes in children with idiopathic pulmonary arterial hypertension Circulation 2004 110 6 660 665 (Pubitemid 39056263)
2. Khemani E., McElhinney D. B., Rhein L., Andradeb O., Lacro R. V., Thomas K. C., Mullen M. P., Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era Pediatrics 2007 120 6 1260 1269 (Pubitemid 350223677)
3. Robbins I. M., Morrow J. D., Christman B. W., Oxidant stress but not thromboxane decreases with epoprostenol therapy Free Radical Biology and Medicine 2005 38 5 568 574 (Pubitemid 40416852)
4. Roberts L. J. M., Morrow J. D., Measurement of F 2 -isoprostanes as an index of oxidative stress in vivo Free Radical Biology and Medicine 2000 28 4 505 513 (Pubitemid 30136031)
5. Janssen L. J., Isoprostanes and lung vascular pathology American Journal of Respiratory Cell and Molecular Biology 2008 39 4 383 389
6. Morrow J. D., Roberts L. J., Mass spectrometric quantification of F 2 -isoprostanes in biological fluids and tissues as measure of oxidant stress Methods in Enzymology 1998 300 3 12 (Pubitemid 28500576)
7. Harris P. A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J. G., Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support Journal of Biomedical Informatics 2009 42 2 377 381
8. Kang K. M., Morrow J. D., Roberts L. J., Newman J. H., Banerjee M., Airway and vascular effects of 8-epi-prostaglandin F(2 ) in isolated perfused rat lung Journal of Applied Physiology 1993 74 1 460 465 (Pubitemid 23059782)
9. Ahola T., Fellman V., Kjellmer I., Raivio K. O., Lapatto R., Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia Pediatric Research 2004 56 1 88 93 (Pubitemid 38808547)
10. Comporti M., Signorini C., Leoncini S., Buonocore G., Rossi V., Ciccoli L., Plasma F 2 -isoprostanes are elevated in newborns and inversely correlated to gestational age Free Radical Biology and Medicine 2004 37 5 724 732 (Pubitemid 38993518)
11. Stenmark K. R., Abman S. H., Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia Annual Review of Physiology 2005 67 623 661 (Pubitemid 40404504)
12. Milne G. L., Yin H., Morrow J. D., Human biochemistry of the isoprostane pathway Journal of Biological Chemistry 2008 283 23 15533 15537
13. Fessel J. P., Porter N. A., Moore K. P., Sheller J. R., Roberts L. J., Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension Proceedings of the National Academy of Sciences of the United States of America 2002 99 26 16713 16718 (Pubitemid 36034038)